Published in BMC Med Genomics on March 14, 2014
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Immunosuppressive drugs for kidney transplantation. N Engl J Med (2004) 4.09
Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant (2006) 3.58
Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA (1993) 3.10
Delayed graft function in kidney transplantation. Lancet (2004) 3.06
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
The nuclear pore complex as a transport machine. J Biol Chem (2001) 2.96
Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant (2011) 2.69
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation (1995) 2.67
Transport routes through the nuclear pore complex. Curr Opin Cell Biol (1998) 2.50
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Delayed graft function in the kidney transplant. Am J Transplant (2011) 2.06
Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol (1998) 2.01
Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha. EMBO J (2002) 2.01
Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein. J Biol Chem (2003) 1.81
An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A (2001) 1.73
Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation (2005) 1.64
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation. Kidney Int (2013) 1.61
Nucleocytoplasmic shuttling of STAT transcription factors. Eur J Biochem (2004) 1.54
Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation (1997) 1.48
The ins and outs of STAT1 nuclear transport. Sci STKE (2003) 1.47
Towards reconciling structure and function in the nuclear pore complex. Histochem Cell Biol (2008) 1.45
Importazole, a small molecule inhibitor of the transport receptor importin-β. ACS Chem Biol (2011) 1.39
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J (2012) 1.36
Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant (2006) 1.34
Changes in quality of life after renal transplantation. Am J Kidney Dis (1998) 1.31
Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol (1996) 1.28
Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrol Dial Transplant (2007) 1.20
The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant (2007) 1.13
The molecular mechanism of transport of macromolecules through nuclear pore complexes. Traffic (2000) 1.08
The nature of renal cell injury. Kidney Int (1997) 1.06
Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int (2000) 0.98
Predictive ability of pretransplant comorbidities to predict long-term graft loss and death. Am J Transplant (2008) 0.97
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol (2004) 0.96
Nanoscale mechanism of molecular transport through the nuclear pore complex as studied by scanning electrochemical microscopy. J Am Chem Soc (2013) 0.91
Role of transcription factors in small intestinal ischemia-reperfusion injury and tolerance induced by ischemic preconditioning. Transplant Proc (2010) 0.89
Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment. PLoS One (2012) 0.88
An AlphaScreen®-based assay for high-throughput screening for specific inhibitors of nuclear import. J Biomol Screen (2011) 0.88
Post kidney transplant quality of life prediction models. Clin Transplant (1998) 0.88
Serum neutrophil gelatinase-associated lipocalin and interleukin-18 as predictive biomarkers for delayed graft function after kidney transplantation. J Clin Lab Anal (2012) 0.85
Delayed renal graft function: risk factors and impact on the outcome of transplantation. Transplant Proc (2011) 0.84
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. Transpl Int (2010) 0.83
The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase. J Am Soc Nephrol (2010) 0.82
Nuclear transport: never-ending cycles of signals and receptors. Essays Biochem (2000) 0.81
Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcome. Mol Med (2011) 0.81
Induction antibody therapy in kidney transplantation. Am J Kidney Dis (2009) 0.81
Prediction of delayed graft function by means of a novel web-based calculator: a single-center experience. Am J Transplant (2011) 0.80
Pretransplant inflammation: a risk factor for delayed graft function? J Nephrol (2008) 0.78
Early metabolic changes in peripheral blood cells of renal transplant recipients treated with cyclosporine A. Int J Immunopharmacol (1999) 0.77
Clinical determinants of multiple acute rejection episodes in kidney transplant recipients. Transplantation (2000) 0.77
Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med (2005) 7.83
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol (2006) 3.95
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int (2014) 3.40
Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet (2011) 3.15
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Distinctive Paleo-Indian migration routes from Beringia marked by two rare mtDNA haplogroups. Curr Biol (2009) 2.78
Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol (2009) 2.70
Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol (2007) 2.42
Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med (2008) 2.25
Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol (2005) 2.18
Mitochondrial genomes of extinct aurochs survive in domestic cattle. Curr Biol (2008) 2.14
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J Exp Med (2002) 1.95
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int (2004) 1.79
Medullary sponge kidney: state of the art. Nephrol Dial Transplant (2012) 1.76
Comparative study of gene set enrichment methods. BMC Bioinformatics (2009) 1.74
Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrol Dial Transplant (2004) 1.73
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet (2012) 1.69
Systemic inflammation, metabolic syndrome and progressive renal disease. Nephrol Dial Transplant (2009) 1.63
Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet (2012) 1.63
Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study. Nephrol Dial Transplant (2012) 1.61
Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant (2014) 1.61
Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol Dial Transplant (2008) 1.57
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation (2009) 1.56
Sirolimus interferes with iron homeostasis in renal transplant recipients. Transplantation (2006) 1.55
Straight screw-in atrial leads "J-post shaped" in right appendage versus J-shaped systems for permanent atrial pacing: a safety comparison. Pacing Clin Electrophysiol (2011) 1.52
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int (2012) 1.52
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol (2012) 1.51
Mitochondrial DNA signals of late glacial recolonization of Europe from near eastern refugia. Am J Hum Genet (2012) 1.49
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy. Kidney Int (2012) 1.46
Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients. Transplantation (2003) 1.46
Monitoring biological action of rapamycin in renal transplantation. Am J Kidney Dis (2007) 1.43
Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes. Diabetes Care (2006) 1.43
Management of side effects of sirolimus therapy. Transplantation (2009) 1.43
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial. Nephrol Dial Transplant (2013) 1.41
Biosimilars and safety issues. Leuk Lymphoma (2009) 1.40
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol Immunol (2007) 1.39
Kinetics of the circulating levels of bone alkaline phosphatase in a case of hungry bone disease following total parathyroidectomy. Ann Ital Med Int (2004) 1.39
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients. Nephrol Dial Transplant (2004) 1.38
TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J (2009) 1.33
Mitochondrial haplogroup U5b3: a distant echo of the epipaleolithic in Italy and the legacy of the early Sardinians. Am J Hum Genet (2009) 1.32
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. J Proteomics (2011) 1.28
Mitochondrial DNA variation of modern Tuscans supports the near eastern origin of Etruscans. Am J Hum Genet (2007) 1.28
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int (2011) 1.22
CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant (2009) 1.21
Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets. Genome Res (2011) 1.20
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol (2010) 1.18
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics (2009) 1.16
WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes. Pediatr Nephrol (2006) 1.16
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol (2010) 1.15
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am J Pathol (2010) 1.12
HmtDB, a human mitochondrial genomic resource based on variability studies supporting population genetics and biomedical research. BMC Bioinformatics (2005) 1.10
Prolonged conservative treatment for frail elderly patients with end-stage renal disease: the Verona experience. Nephrol Dial Transplant (2007) 1.10
Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. J Nephrol (2009) 1.10
Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy. Diabetes Care (2010) 1.09
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. J Biol Chem (2011) 1.07
Endovascular versus surgical preemptive repair of forearm arteriovenous fistula juxta-anastomotic stenosis: analysis of data collected prospectively from 1999 to 2004. Clin J Am Soc Nephrol (2006) 1.07
Goodpasture's disease: a report of ten cases and a review of the literature. Autoimmun Rev (2013) 1.05
Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. J Am Soc Nephrol (2005) 1.04
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int (2008) 1.04
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant (2010) 1.03
Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction. J Pediatr Surg (2011) 1.02
Characterization of two novel missense mutations in the AQP2 gene causing nephrogenic diabetes insipidus. Nephron Physiol (2006) 1.02
Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics (2008) 1.02
Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 1.01
Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transplant (2010) 1.01
Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma. Int J Cancer (2008) 1.00
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS. J Biomed Biotechnol (2010) 0.99
Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour. BMC Med Genomics (2009) 0.99
Increase of proliferating renal progenitor cells in acute tubular necrosis underlying delayed graft function. Transplantation (2008) 0.98
Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem (2006) 0.98
Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients. Nephrol Dial Transplant (2004) 0.98
Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy. Kidney Int (2010) 0.97
TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype. Clin J Am Soc Nephrol (2011) 0.97
BMP-2 induces a profibrotic phenotype in adult renal progenitor cells through Nox4 activation. Am J Physiol Renal Physiol (2012) 0.96
Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin. J Am Soc Nephrol (2004) 0.96
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. Clin Cancer Res (2003) 0.96
Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells. Biochim Biophys Acta (2011) 0.96
Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma. Medicine (Baltimore) (2014) 0.94
Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis. J Am Soc Nephrol (2003) 0.94